BioSpace News Archive

Business

Zynex Schedules 2017 Third Quarter Earnings Release and Webcast

The Company expects to file its 2017 third quarter financial results on Monday, November 13, 2017.

November 7, 2017

·

2 min read

Biotech Bay

Fitbit Selected for NIH Precision Medicine Research Program With The Scripps Research Institute

Researchers will use data gathered from the program to learn more about how individual differences in lifestyle, environment and biological makeup can influence health and disease.

November 7, 2017

·

4 min read

Drug Development

OncoQuest Announces Presentation of Translational Immunology Data from Phase II Clinical Study Examining Oregovomab

The findings presented were drawn from the 81 patients in the trial from the Italian investigative centers.

November 7, 2017

·

3 min read

Policy

Batu Biologics Receives FDA Clearance for First Multi-Pronged Immunotherapy Targeting the Blood Vessels That Feed Cancer

Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax™, has received an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) allowing Batu to proceed with Phase 1 clinical trials.

November 7, 2017

·

3 min read

Pharm Country

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

In addition, Fortress has granted the underwriters a 30-day option to purchase up to 150,000 additional shares at the public offering price, less underwriting discounts and commissions.

November 7, 2017

·

4 min read

Policy

Collegium Receives FDA Approval for sNDA for Xtampza ER

With approval of the sNDA, the updated label for Xtampza ER includes three main changes.

November 7, 2017

·

10 min read

Policy

Sarepta Therapeutics Announces FDA Clearance of IND for the Company’s PPMO Exon 51 Candidate, SRP-5051

Sarepta to immediately initiate a Phase 1/2a clinical trial in patients with Duchenne muscular dystrophy (DMD) amenable to skipping exon 51.

November 7, 2017

·

8 min read

Business

Evoke Pharma Schedules Conference Call and Webcast for Third Quarter 2017 Financial Results

Evoke will hold a conference call on Tuesday, November 14, 2017 at 4:30 pm ET to discuss the results.

November 7, 2017

·

1 min read

Biotech Beach

The Scripps Research Institute Scientists Find Potential “Missing Link” in Chemistry That Led to Life on Earth

Chemists at The Scripps Research Institute have found a compound that may have been a crucial factor in the origins of life on Earth.

November 7, 2017

·

4 min read

Drug Development

Cellectar Announces Updated Median Overall Survival of 26.2 Months from Cohort 1 of CLR 131 Phase I Trial in Advanced Multiple Myeloma

While no head-to-head studies have been conducted for comparison, the median overall survival benefit seen with the three most recently FDA-approved third line therapies for multiple myeloma ranges from 11.9 – 18.6 months in separate trials.

November 7, 2017

·

5 min read